Dn B Asset Management As Moon Lake Immunotherapeutics Transaction History
Dn B Asset Management As
- $19.9 Billion
- Q2 2024
A detailed history of Dn B Asset Management As transactions in Moon Lake Immunotherapeutics stock. As of the latest transaction made, Dn B Asset Management As holds 7,372 shares of MLTX stock, worth $336,015. This represents 0.0% of its overall portfolio holdings.
Number of Shares
7,372
Previous 5,678
29.83%
Holding current value
$336,015
Previous $285,000
13.68%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding MLTX
# of Institutions
127Shares Held
58MCall Options Held
103KPut Options Held
79.7K-
Bvf Inc San Francisco, CA21.8MShares$991 Million29.25% of portfolio
-
Cormorant Asset Management, LP Boston, MA8.49MShares$387 Million28.74% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.77MShares$126 Million1.66% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.56MShares$117 Million0.01% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il2.27MShares$103 Million0.02% of portfolio
About MoonLake Immunotherapeutics
- Ticker MLTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,925,600
- Market Cap $1.68B
- Description
- MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies. It is developing Sonelokimab, a novel investigational Nanobody therapy for the treatment of inflammation. The company is involved in conducting Phase II trials for hidradenitis suppurativa, psoriatic arthritis, ankylosing spondylitis, or rad...